What does Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR do?

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR is a public company, incorporated in F4. It is registered with the SEC under CIK 0002071868 and trades on OTC under the ticker JNGHF.

How many SEC filings has Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR made?

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR has filed 2 documents with the SEC since 2025. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR

JNGHF OTC CIK: 0002071868 Inc. in F4

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 2 filings →

Form	Description	Date
F-6EF	F-6EF	Nov 5, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0002071868
Ticker: JNGHF
Exchange: OTC
Incorporated: F4
First Filing: 2025
Total Filings: 2